Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.69 |
| ▸ | NPY1R | P25929 | 1/20 | 0.64 |
| ▸ | NPY2R | P49146 | 1/20 | 0.64 |
| ▸ | NPY4R | P50391 | 1/20 | 0.64 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.64 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.63 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.63 |
| ▸ | GLP1R | P43220 | 4/20 | 0.63 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.61 |
| ▸ | EED | O75530 | 1/20 | 0.60 |
| ▸ | GCGR | P47871 | 1/20 | 0.60 |
| ▸ | GIPR | P48546 | 1/20 | 0.60 |
| ▸ | PTH1R | Q03431 | 5/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30495825 | 0.91 | NPY2R (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 | |
| SCHEMBL31182720 | 0.90 | NPY2R (0.69) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30658309 | 0.90 | KEAP1 (0.68) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31182525 | 0.90 | NPY2R (0.67) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL28972123 | 0.90 | KEAP1 (0.69) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30607471 | 0.89 | NPY2R (0.68) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30864786 | 0.89 | C5AR1 (0.59) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30404538 | 0.89 | KEAP1 (0.65) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL29827497 | 0.89 | NPY2R (0.69) | KEAP1NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30804658 | 0.89 | NPY2R (0.73) | NPY1RNPY2RNPY4RNPY5RCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | claimed |
| WO-2024184403-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR BIOME APS (DK) | 2024-09-12 | — | — | WO | claimed |
| CN-112402403-B | Application of deoxyshikonin in preparation of host defense peptide expression promoter | 北京市农林科学院 | 2022-06-21 | — | — | CN | claimed |
| CN-114146214-A | Hydrogel containing antibacterial peptide and preparation method and application thereof | 河南科技大学 | 2022-03-08 | — | — | CN | claimed |
| EP-4677075-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR Biome ApS (DK) | 2026-01-14 | — | — | EP | disclosed |
| US-20260002165-A1 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR BIOME APS (DK) | 2026-01-01 | — | — | US | disclosed |
| US-20250034218-A1 | ANTIMICROBIAL PEPTIDES | BIOMEDIT, INC. | 2025-01-30 | — | — | US | disclosed |
| CN-118829681-A | Heparin from waste tissue of slaughtered animals and mixtures of natural proteins and peptides | 霍里松IP有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024184403-A2 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | SNIPR BIOME APS (DK) | 2024-09-12 | — | — | WO | disclosed |
| CN-118556072-A | Antibacterial peptide | 生物编辑有限责任公司 | 2024-08-27 | — | — | CN | disclosed |
| EP-4387731-A1 | ANTIMICROBIAL PEPTIDES | BiomEdit, LLC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20240165200-A1 | CATH2 AND DERIVATIVES FOR INHIBITING STREPTOCOCCUS SUIS | UNIVERSITEIT UTRECHT HOLDING B.V. (NL) | 2024-05-23 | — | — | US | disclosed |
| CN-112402403-B | Application of deoxyshikonin in preparation of host defense peptide expression promoter | 北京市农林科学院 | 2022-06-21 | — | — | CN | disclosed |
| CN-113024653-B | Pig-derived antibacterial peptide PMAP-23 variant and application thereof in preparation of feed | 山东中科康源生物科技有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-113024653-B | Pig-derived antibacterial peptide PMAP-23 variant and application thereof in preparation of feed | 山东中科康源生物科技有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-113024653-B | Pig-derived antibacterial peptide PMAP-23 variant and application thereof in preparation of feed | 山东中科康源生物科技有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-113087781-B | Antibacterial peptide and application thereof | 山东中科康源生物科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-113087781-B | Antibacterial peptide and application thereof | 山东中科康源生物科技有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-114146214-A | Hydrogel containing antibacterial peptide and preparation method and application thereof | 河南科技大学 | 2022-03-08 | — | — | CN | disclosed |
| CN-114146214-A | Hydrogel containing antibacterial peptide and preparation method and application thereof | 河南科技大学 | 2022-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034218-A1 | ANTIMICROBIAL PEPTIDES | CAPG, ZC3H18, CACYBP | KEAP1 3366/4885NPY1R 3321/4885NPY2R 3055/4885 |
| US-20260002165-A1 | TARGETING CELLS IN STRESSED GROWING CONDITIONS | ATF4, BACH1, ATF1 | KEAP1 1480/4885NPY1R 2656/4885NPY2R 3572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.